Detalhe da pesquisa
1.
Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma.
Blood
; 140(21): 2248-2260, 2022 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35839452
2.
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.
Blood
; 139(3): 413-423, 2022 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34570876
3.
Myocardial strain is associated with adverse cardiac events in patients treated with chimeric antigen receptor (CAR) T-cell therapy.
Eur J Haematol
; 112(1): 102-110, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37649240
4.
Dosing of 7 + 3 induction chemotherapy in a patient with acute myeloid leukemia (AML) and morbid obesity.
J Oncol Pharm Pract
; : 10781552241240444, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38509800
5.
Humoral Immunity After COVID-19 Vaccination in Chronic Lymphocytic Leukemia and Other Indolent Lymphomas: A Single-Center Observational Study.
Oncologist
; 28(10): e930-e941, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37141401
6.
Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma.
Blood
; 137(10): 1318-1326, 2021 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32992341
7.
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers.
Blood
; 137(3): 374-386, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32663292
8.
Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study.
Haematologica
; 2023 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37855051
9.
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers.
Am J Hematol
; 98(6): 900-912, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36965007
10.
Targeted reduction of cholesterol uptake in cholesterol-addicted lymphoma cells blocks turnover of oxidized lipids to cause ferroptosis.
J Biol Chem
; 296: 100100, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33208460
11.
Cachexia is a risk factor for negative clinical and functional outcomes in patients receiving chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma.
Br J Haematol
; 197(1): 71-75, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35141891
12.
De novo emergence of SARS-CoV-2 spike mutations in immunosuppressed patients.
Transpl Infect Dis
; 24(6): e13914, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35899968
13.
Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study.
Haematologica
; 106(7): 1932-1942, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538152
14.
Impact of initial chemotherapy regimen on outcomes for patients with double-expressor lymphoma: A multi-center analysis.
Hematol Oncol
; 39(4): 473-482, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34347909
15.
Histiocytic Neoplasms, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 19(11): 1277-1303, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34781268
16.
Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival.
Eur J Haematol
; 107(3): 301-310, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33973276
17.
Multi-center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era.
Am J Hematol
; 96(11): 1374-1384, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34324220
18.
B Cell Lymphomas of the GI Tract.
Curr Gastroenterol Rep
; 23(7): 9, 2021 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33963950
19.
Higher Total Body Irradiation Dose Intensity in Fludarabine/TBI-Based Reduced-Intensity Conditioning Regimen Is Associated with Inferior Survival in Non-Hodgkin Lymphoma Patients Undergoing Allogeneic Transplantation.
Biol Blood Marrow Transplant
; 26(6): 1099-1105, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32165327
20.
Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.
Cancer
; 126(2): 293-303, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31568564